CAS 102669-89-6: Saterinone
Formula:C27H30N4O4
InChI:InChI=1/C27H30N4O4/c1-19-24(15-21(16-28)27(33)29-19)20-7-9-23(10-8-20)35-18-22(32)17-30-11-13-31(14-12-30)25-5-3-4-6-26(25)34-2/h3-10,15,22,32H,11-14,17-18H2,1-2H3,(H,29,33)
SMILES:Cc1c(cc(C#N)c(n1)O)c1ccc(cc1)OCC(CN1CCN(CC1)c1ccccc1OC)O
Synonyms:- Saterinone [INN]
- (+-)-1,2-Dihydro-5-(p-(2-hydroxy-3-(4-(o-methoxyphenyl)-1-piperazinyl)propoxy)phenyl)-6-methyl-2-oxonicotinonitrile
- Saterinona
- Saterinona [Spanish]
- Saterinonum
- Saterinonum [Latin]
- Unii-W4P85Fo7Gs
- 5-(4-{2-Hydroxy-3-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Propoxy}Phenyl)-6-Methyl-2-Oxo-1,2-Dihydropyridine-3-Carbonitrile
Sort by
Found 4 products.
Saterinone
CAS:Saterinone is a cardiac glycoside that binds to the beta-adrenergic receptor. Saterinone has been shown to reduce the incidence of cancer and bowel disease in rats, as well as the severity of bowel disease. It is also used for the treatment of congestive heart failure and inflammatory bowel disease. This drug has inhibitory properties on isolated heart muscle cells, which are mediated by its ability to bind to the beta-adrenergic receptor. Furthermore, saterinone may have a role in blood pressure monitoring because it inhibits angiotensin II-induced contraction of isolated vascular smooth muscle cells. Saterinone is an inhibitor of nitroprusside-induced hypotension in rabbits, which may be due to its ability to inhibit nitric oxide synthase (NOS).Formula:C27H30N4O4Purity:Min. 95%Molecular weight:474.6 g/molSaterinone
CAS:Saterinone: PDE III inhibitor, α-1-adrenoceptor antagonist, vasodilator, used for acute chronic heart failure, IC50 2.3x10^-5 M.Formula:C27H30N4O4Purity:98.23%Color and Shape:SolidMolecular weight:474.55Ref: TM-T68138
1mg94.00€5mg221.00€10mg335.00€25mg537.00€50mg730.00€100mg979.00€200mg1,320.00€1mL*10mM (DMSO)261.00€
